Evidence map›Paper›PMID 38902916›Full record

ArticleAnnals of transplantation2024

Long-Term Graft and Patient Survival After Re-Transplantation.

Dana Bielopolski, Aviad Gravetz, Timna Agur, Renana Yemini, Benaya Rozen Zvi, Eviatar Nesher

Abstract read
In one paragraph

Article in Annals of transplantation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dana BielopolskiNephrology and Hypertension Institute, Rabin Medical Center, Petach Tikva, Israel.ORCID 0000-0001-9476-0032
Aviad GravetzDepartment of Transplant Surgery, Rabin Medical Center, Petach Tikva, Israel.ORCID 0000-0003-1658-1180
Timna AgurNephrology and Hypertension Institute, Rabin Medical Center, Petah Tikva, Israel.ORCID 0000-0001-8263-0900
Renana YeminiDivision of Transplant Surgery, Department of Surgery, University of Virginia Health System, Charlottesville, VA, USA.ORCID 0000-0002-3910-0979
Benaya Rozen ZviNephrology and Hypertension Institute, Rabin Medical Center, Petah Tikva, Israel.ORCID 0000-0002-8303-7794
Eviatar NesherDepartment of Transplant Surgery, Beilinson Medical Center, Petah Tikva, Israel.ORCID 0000-0002-8753-2688

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Kidney transplant recipients have higher life expectancy but may require subsequent transplantations, raising ethical concerns regarding organ allocation. We assessed the safety of multiple kidney transplants through long-term follow-up. MATERIAL AND METHODS A retrospective cohort study was conducted at a single center, categorizing patients based on the number of kidney transplantations received. The primary outcome was the composite of death-censored graft failure and overall mortality. The secondary outcome was death-censored graft failure. RESULTS Between 2000 and 2019, our center performed 2152 kidney transplantations. Patients were divided into 3 groups: A (1 transplant; n=1850), B (2 transplants; n=285), and C (3 or more transplants; n=75). Group C patients were younger, had fewer comorbidities, and received more aggressive induction therapy. The primary outcomes, including death-censored graft loss and overall mortality, showed similar rates across groups (A: 21.3%, B: 25.2%, C: 21.7%, p=0.068). However, the secondary outcome of death-censored graft failure alone was significantly lower in group A compared to the other groups. No significant difference was observed between groups B and C (8% vs 16% and 13%, respectively, p=0.001, p=0.845). Multivariate analysis identified having a living donor as the strongest predictor of patient and graft survival in all study groups. CONCLUSIONS Graft and patient survival rates were similar between first and multiple transplant recipients. Multiple transplant recipients had lower death-censored graft failure risk compared to first transplant recipients. However, the risk did not differ among second and subsequent transplant recipients. Younger patients, especially those with a living donor, should be considered for repeat kidney transplantation.

Indexed as

Graft SurvivalKidney TransplantationReoperationAdultAgedFemaleGraft RejectionHumansMaleMiddle AgedRetrospective StudiesSurvival Rate

Identifiers

PMID38902916
PMCPMC11299480

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.